R, L., & I, S. (2019). How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 47(3), 369. https://doi.org/10.1177/1073110519876165
Chicago Style (17th ed.) CitationR, Li, and Sim I. "How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers." The Journal of Law, Medicine & Ethics : A Journal of the American Society of Law, Medicine & Ethics 47, no. 3 (2019): 369. https://doi.org/10.1177/1073110519876165.
MLA (9th ed.) CitationR, Li, and Sim I. "How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers." The Journal of Law, Medicine & Ethics : A Journal of the American Society of Law, Medicine & Ethics, vol. 47, no. 3, 2019, p. 369, https://doi.org/10.1177/1073110519876165.